Ovid Therapeutics
OVID
OVID
35 hedge funds and large institutions have $18.7M invested in Ovid Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-15
Holders Change %
-30%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
11
Reduced
15
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$820K |
| 2 |
Millennium Management
New York
|
+$644K |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$537K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$238K |
| 5 |
Renaissance Technologies
New York
|
+$200K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$3.15M |
| 2 |
BlackRock
New York
|
-$973K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$457K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$398K |
| 5 |
State Street
Boston,
Massachusetts
|
-$333K |
